Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03636451 · ClinicalTrials.gov registry record · Phase 3
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 114
- Enrollment target
NCT03636451 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 114 participants.
The verdict
NCT03636451, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 114 participants
- Enrollment target
Study Summary
The investigators are conducting a study on pain control for dilation and curettage (D\&C). Participants are eligible to enroll if they are a planning to have a D\&C in a participating clinic. The investigators are studying how different ratios of medication to liquid affect pain when injected around the cervix. Both potential methods use the same dose of medication, though researchers would like to know which one works better. To be in this study, participants must be over the age of 18 with an early pregnancy loss or undesired pregnancy measuring less than 12 weeks gestation undergoing D\&C while awake in clinic.
Interventions
- DRUG 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block
- DRUG 20cc 1% lidocaine with 2 units of vasopressin paracervical block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2022-09-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03636451
The ClinicalTrials.gov registry entry for NCT03636451 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block is the first listed.
NCT03636451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03636451 about?
NCT03636451 is a clinical study titled "Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o". The investigators are conducting a study on pain control for dilation and curettage (D\&C). Participants are eligible to enroll if they are a planning to have a D\&C in a participating clinic. The investigators are studying how different ratios of medication to liquid affect pain when injected aroun...
What is the current status of trial NCT03636451?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 114 participants. The study started on 2018-10-29. Estimated completion is 2022-09-27.
What interventions are being tested in trial NCT03636451?
The interventions under investigation include: 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block (DRUG), 20cc 1% lidocaine with 2 units of vasopressin paracervical block (DRUG).
Who is sponsoring clinical trial NCT03636451?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.